ReviewFundamental research2025
Innovating transcranial magnetic stimulation treatment for post-traumatic stress disorder: Zapping away the bad memory.
Review in Fundamental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Oxytocin preserves excitatory responsiveness of VTA dopaminergic neurons in PTSD model rats.IBRO neuroscience reports · 2026Article
- Closed-Loop Neuromodulation for Brain Fatigue: From Real-Time Biomarkers to Adaptive Intervention.International journal of molecular sciences · 2026Review
- Physical biomedical science.Fundamental research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-traumatic stress disorder (PTSD) is a debilitating psychiatric condition characterized by dysregulated fear memory, emotional disturbances, and impaired cognition, driven by dysfunctions across multiple neural circuits and neuroinflammatory processes. While current treatments demonstrate limited efficacy, repetitive transcranial magnetic stimulation (rTMS) has emerged as a promising non-invasive intervention. This review synthesizes preclinical and clinical evidence, highlighting rTMS mechanisms-including enhanced neuroplasticity, normalizing network connectivity, and reducing neuroinflammation. We then propose five innovative strategies, including accelerated protocols, precision targeting using neuroimaging, neuroinformatic approaches, closed-loop systems, and biomarker-guided treatment. By bridging circuit-level insights with clinical innovation, rTMS offers a transformative approach to PTSD treatment, though standardization and personalized paradigms require further development and validation. Future research should integrate multimodal biomarkers with hybrid therapies to optimize outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.